Search Results 1671-1680 of 21356 for anti-TNF drugs

1. Overview - Precision Neurotherapeutics Innovation Program - Mayo Clinic Research

   A person diagnosed with a glioblastoma asks a Mayo Clinic physician, "What now?" Standard treatment options — including surgery, radiation or chemotherapy — ...

2. A Study to Evaluate Effectiveness and Safety of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia (Enrolling by Invitation Only) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Use of any FDA approved anti-IL-6 (e.g., tocilizumab, sarilumab, ...

3. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

   Requires therapy with agents ... agents, corticosteroids or immunosuppressive drugs). ... Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent.

4. Lopinavir And Ritonavir (Oral Route) Proper Use - Mayo Clinic

   This medicine comes with a Medication Guide. Read and follow the instructions carefully before starting treatment and each time you refill your prescription.

5. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery - Mayo Clinic

   Patients with HER2-positive tumors must have received neoadjuvant trastuzumab or other anti-HER2 therapy (either with all or with a portion of the neoadjuvant ...

6. Publications - Jiasen Ma, Ph.D. - Mayo Clinic

   ... treatment with anti-PD-1 in patients with metastatic melanoma. Cancer. 2019 Dec 1; 125 (23):4193-4202 Epub 2019 Aug 09. View PubMed; Lu J, Wu J, Xie F, Tian J ...

7. Torsemide (Oral Route) Proper Use - Mayo Clinic

   In addition to the use of the medicine your doctor has prescribed, treatment for your high blood pressure may include weight control and care in the types of ...

8. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Any approved anti-cancer therapy, including chemotherapy or hormonal therapy, within 3 weeks prior to initiation of study treatment, with the following ...

9. Atorvastatin And Ezetimibe (Oral Route) Description and Brand Names - Mayo Clinic

   Ezetimibe is a cholesterol absorption inhibitor and atorvastatin is an HMG-CoA reductase inhibitor, or statin. These medicines will reduce the absorption of ...

10. Immune Globulin-Ifas (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Panzyga. Descriptions. Immune globulin-ifas injection ...